Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;171(4):468-471.
doi: 10.1007/s10517-021-05252-x. Epub 2021 Sep 20.

Photodynamic Therapy of Melanoma B16 with Chlorin E6 Conjugated with a PSMA-Ligand

O B Abramova  1 , M A Kaplan  2 , M A Grin  3 , V V Yuzhakov  2 , N V Suvorov  3 , A F Mironov  3 , V V Drozhzhina  2 , T P Churikova  2 , E A Kozlovtseva  2 , L N Bandurko  2 , N D Yakovleva  2 , S A Ivanov  2 , A D Kaprin  2
Affiliations

Photodynamic Therapy of Melanoma B16 with Chlorin E6 Conjugated with a PSMA-Ligand

O B Abramova et al. Bull Exp Biol Med. 2021 Aug.

Abstract

The efficacy of a new photosensitizer of chlorin E6 conjugated with a prostate-specific membrane antigen (PSMA) in photodynamic therapy of murine melanoma B16 was studied in in vivo experiments. The dynamics of photosensitizer accumulation in the tumor and surrounding tissues was evaluated and antitumor efficacy of photodynamic therapy was assessed by parameters of regression and morphological characteristics of experimental transplanted melanoma B16. The inhibitory effect of photodynamic therapy on melanoma was evaluated by complete regression of the tumor, absolute tumor growth coefficient in animals with continuation of tumor growth, and the increase in life span in comparison with the control; the criterion of cure was the absence of signs of tumor recurrence in mice within 90 days after therapy. The therapeutic potential of photodynamic therapy was determined by devitalization of tumor cells (histological examination of the zones of laser exposure on day 21 after treatment). The photosensitizer with PSMA-ligand exhibited high antitumor activity in photodynamic therapy for melanoma B16. Photodynamic therapy carried out at the optimum time after photosensitizer injection with experimentally determined parameters of laser exposure allows achieving the maximum inhibitory effect on melanoma. Pathomorphological study in the zones of exposure detected no survived tumor cells.

Keywords: melanoma B16; pathomorphology; pharmacokinetics; photodynamic therapy; photosensitizer chlorin E6 with PSMAligand.

PubMed Disclaimer

References

    1. Burmistrova NV, Drozhzhina VV, Kaplan MA, Yuzhakov VV, Bandurko LN, Tsyganova MG, Ivanov SA, Arkhipova LM, Abramova OB. Study of efficiency of photodynamic therapy of Earlich carcinoma mice with intravenous introduction of photosensibilizer of liposomal boronated chlorine E6. Radiats. Risk. 2019;28(4):96-107. doi: https://doi.org/10.21870/0131-3878-2019-28-4-96-107 . Russian. - DOI
    1. Grin MA, Suvorov NV, Machulkin AE, Plotnikova EA, Yakubovskaya RI, Mazhuga AG, Mironov AF, Filonenko EV. Patent RU No. 2670087. Photosensitizer for photodynamic therapy of prostate cancer and method for manufacturing thereof. Bull. No. 29. Published October 18, 2018.
    1. Bařinka C, Rojas C, Slusher B, Pomper M. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr. Med. Chem. 2012;19(6):856-870. doi: https://doi.org/10.2174/092986712799034888 - DOI - PubMed - PMC
    1. Davis MI, Bennett MJ, Thomas LM, Bjorkman PJ. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc. Natl Acad. Sci. USA. 2005;102(17):5981-5986. doi: https://doi.org/10.1073/pnas.0502101102 - DOI - PubMed - PMC
    1. Nimmagadda S, Pullambhatla M, Chen Y, Parsana P, Lisok A, Chatterjee S, Mease R, Rowe SP, Lupold S, Pienta KJ, Pomper MG. Low-level endogenous PSMA expression in nonprostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging. J. Nucl. Med. 2018;59(3):486-493. doi: https://doi.org/10.2967/jnumed.117.191221 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources